Cargando…

Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α

Oropharyngeal squamous cell cancer (OPC) accounts for 3% of all cancers and greater than 1.5% of all cancer deaths in the United States, with marked treatment-associated morbidity in survivors. More than 80% of OPC is caused by HPV16. Tumors induced by HPV have been linked to impaired immune functio...

Descripción completa

Detalles Bibliográficos
Autores principales: DeVoti, James A., Israr, Mohd, Lam, Fung, Papayannakos, Christopher, Frank, Douglas K., Kamdar, Dev P., Pereira, Lucio M., Abramson, Allan, Steinberg, Bettie M., Bonagura, Vincent R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681149/
https://www.ncbi.nlm.nih.gov/pubmed/36426368
http://dx.doi.org/10.3389/fimmu.2022.1011772
_version_ 1784834554592231424
author DeVoti, James A.
Israr, Mohd
Lam, Fung
Papayannakos, Christopher
Frank, Douglas K.
Kamdar, Dev P.
Pereira, Lucio M.
Abramson, Allan
Steinberg, Bettie M.
Bonagura, Vincent R.
author_facet DeVoti, James A.
Israr, Mohd
Lam, Fung
Papayannakos, Christopher
Frank, Douglas K.
Kamdar, Dev P.
Pereira, Lucio M.
Abramson, Allan
Steinberg, Bettie M.
Bonagura, Vincent R.
author_sort DeVoti, James A.
collection PubMed
description Oropharyngeal squamous cell cancer (OPC) accounts for 3% of all cancers and greater than 1.5% of all cancer deaths in the United States, with marked treatment-associated morbidity in survivors. More than 80% of OPC is caused by HPV16. Tumors induced by HPV have been linked to impaired immune functions, with most studies focused on the local tumor microenvironment. Fewer studies have characterized the effects of these tumors on systemic responses in OPC, especially innate responses that drive subsequent adaptive responses, potentially creating feed-back loops favorable to the tumor. Here we report that elevated plasma levels of PGE(2) are expressed in half of patients with OPC secondary to overexpression of COX-2 by peripheral blood monocytes, and this expression is driven by IL-1α secreted by the tumors. Monocytes from patients are much more sensitive to the stimulation than monocytes from controls, suggesting the possibility of enhanced immune-modulating feed-back loops. Furthermore, control monocytes pre-exposed to PGE(2) overexpress COX-2 in response to IL-1α, simulating responses made by monocytes from some OPC patients. Disrupting the PGE(2)/IL-1α feed-back loop can have potential impact on targeted medical therapies.
format Online
Article
Text
id pubmed-9681149
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96811492022-11-23 Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α DeVoti, James A. Israr, Mohd Lam, Fung Papayannakos, Christopher Frank, Douglas K. Kamdar, Dev P. Pereira, Lucio M. Abramson, Allan Steinberg, Bettie M. Bonagura, Vincent R. Front Immunol Immunology Oropharyngeal squamous cell cancer (OPC) accounts for 3% of all cancers and greater than 1.5% of all cancer deaths in the United States, with marked treatment-associated morbidity in survivors. More than 80% of OPC is caused by HPV16. Tumors induced by HPV have been linked to impaired immune functions, with most studies focused on the local tumor microenvironment. Fewer studies have characterized the effects of these tumors on systemic responses in OPC, especially innate responses that drive subsequent adaptive responses, potentially creating feed-back loops favorable to the tumor. Here we report that elevated plasma levels of PGE(2) are expressed in half of patients with OPC secondary to overexpression of COX-2 by peripheral blood monocytes, and this expression is driven by IL-1α secreted by the tumors. Monocytes from patients are much more sensitive to the stimulation than monocytes from controls, suggesting the possibility of enhanced immune-modulating feed-back loops. Furthermore, control monocytes pre-exposed to PGE(2) overexpress COX-2 in response to IL-1α, simulating responses made by monocytes from some OPC patients. Disrupting the PGE(2)/IL-1α feed-back loop can have potential impact on targeted medical therapies. Frontiers Media S.A. 2022-11-08 /pmc/articles/PMC9681149/ /pubmed/36426368 http://dx.doi.org/10.3389/fimmu.2022.1011772 Text en Copyright © 2022 DeVoti, Israr, Lam, Papayannakos, Frank, Kamdar, Pereira, Abramson, Steinberg and Bonagura https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
DeVoti, James A.
Israr, Mohd
Lam, Fung
Papayannakos, Christopher
Frank, Douglas K.
Kamdar, Dev P.
Pereira, Lucio M.
Abramson, Allan
Steinberg, Bettie M.
Bonagura, Vincent R.
Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α
title Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α
title_full Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α
title_fullStr Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α
title_full_unstemmed Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α
title_short Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α
title_sort oropharyngeal tumor cells induce cox-2 expression in peripheral blood monocytes by secretion of il-1α
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681149/
https://www.ncbi.nlm.nih.gov/pubmed/36426368
http://dx.doi.org/10.3389/fimmu.2022.1011772
work_keys_str_mv AT devotijamesa oropharyngealtumorcellsinducecox2expressioninperipheralbloodmonocytesbysecretionofil1a
AT israrmohd oropharyngealtumorcellsinducecox2expressioninperipheralbloodmonocytesbysecretionofil1a
AT lamfung oropharyngealtumorcellsinducecox2expressioninperipheralbloodmonocytesbysecretionofil1a
AT papayannakoschristopher oropharyngealtumorcellsinducecox2expressioninperipheralbloodmonocytesbysecretionofil1a
AT frankdouglask oropharyngealtumorcellsinducecox2expressioninperipheralbloodmonocytesbysecretionofil1a
AT kamdardevp oropharyngealtumorcellsinducecox2expressioninperipheralbloodmonocytesbysecretionofil1a
AT pereiraluciom oropharyngealtumorcellsinducecox2expressioninperipheralbloodmonocytesbysecretionofil1a
AT abramsonallan oropharyngealtumorcellsinducecox2expressioninperipheralbloodmonocytesbysecretionofil1a
AT steinbergbettiem oropharyngealtumorcellsinducecox2expressioninperipheralbloodmonocytesbysecretionofil1a
AT bonaguravincentr oropharyngealtumorcellsinducecox2expressioninperipheralbloodmonocytesbysecretionofil1a